Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Use Investigation for Eylea for Neovascular Glaucoma (NVG)

NCT04519619 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04519619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04519619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Use Investigation for Eylea for Neovascular Glaucoma (NVG)
Lead sponsor
Bayer
Phase
Observational
Overall status
Recruiting
Start date
November 27, 2020
Completion date
June 30, 2028
Enrollment
480 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular glaucoma